Intelligent Cardiac Pacing System with Synergistic Technologies
Legal Citation
Summary of the Inventive Concept
An innovative cardiac pacing system that integrates AI, IoT, blockchain, and novel materials to optimize electrode selection, enhance patient outcomes, and revolutionize cardiac care.
Background and Problem Solved
The original patent addressed the challenge of selecting optimal electrode combinations for cardiac pacing. However, it relied on manual input and lacked real-time adaptability. The new inventive concept resolves this limitation by synergistically combining advanced technologies to create a more powerful, intelligent, and connected cardiac pacing system.
Detailed Description of the Inventive Concept
The system comprises a neural network-based processor that analyzes real-time physiological data and historical performance metrics to select the optimal electrode combination. A blockchain-secured data repository stores and analyzes patient-specific electrode configuration data, ensuring secure and personalized care. The system also features a novel, nanomaterial-based electrode design that enhances signal transmission and reduces energy consumption. Machine learning algorithms identify high-risk patients and optimize electrode selection accordingly. An IoT-enabled communication module enables remote monitoring and real-time adjustments to electrode configurations. This integrated system provides unparalleled precision, adaptability, and patient-centric care.
Novelty and Inventive Step
The new claims introduce a paradigm shift in cardiac pacing by combining AI, IoT, blockchain, and novel materials in a single system. This synergy of technologies enables real-time adaptability, personalized care, and unprecedented precision, which is not achievable with the original patent's manual input-based approach.
Alternative Embodiments and Variations
Alternative embodiments may include using different AI algorithms, incorporating additional sensors or data sources, or integrating with other medical devices. Variations may include adapting the system for use in different cardiac conditions or developing specialized modules for specific patient populations.
Potential Commercial Applications and Market
The Intelligent Cardiac Pacing System has vast commercial potential in the cardiac care industry, with potential applications in hospitals, clinics, and remote patient monitoring services. The system's ability to provide personalized care, reduce complications, and enhance patient outcomes can revolutionize the treatment of cardiac conditions, making it an attractive solution for healthcare providers and patients alike.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Cardiac medical devices, specifically implantable cardiac stimulation systems with electrode configuration selection technologies, requiring advanced electrical engineering, biomedical engineering, and signal processing expertise
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer with expertise in cardiac device design, signal processing, neural network technologies, advanced sensor integration, and medical device optimization techniques, holding at least a master's degree with 3-5 years of specialized experience
Obviousness Rationale
A PHOSITA would recognize that the PTD's proposed variations represent predictable technological extensions of the source patent's fundamental electrode configuration selection methodology. The core innovation of intelligent electrode selection remains consistent, with the PTD merely introducing contemporary technological augmentations like AI, machine learning, and IoT integration. These technological enhancements represent natural evolutionary steps in medical device design that would be obvious to a skilled practitioner seeking to improve cardiac pacing system performance.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,795 |
|---|---|
| Title | Method and apparatus to perform electrode combination selection |
| Assignee(s) | Cardiac Pacemakers, Inc. |